Results 11 to 20 of about 209,409 (265)

COVID-19 Drug Treatment in China. [PDF]

Curr Pharmacol Rep, 2020
An unprecedented outbreak of the novel coronavirus in China (COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a significant and urgent threat to global health. Many research institutes have been involved in the development of drugs and vaccines against COVID-19.At present, the strategy of new use of old drugs is ...
Fan L, Jiang S, Yang X, Wang Z, Yang C.
europepmc   +4 more sources

COVID-19: Drug Targets and Potential Treatments [PDF]

Journal of Medicinal Chemistry, 2020
Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19.
Gil, Carmen, Ginex, Tiziana, Maestro, Inés, Nozal, Vanesa, Barrado-Gil, Lucía, Cuesta-Geijo, Miguel Ángel, Urquiza, Jesús, Ramírez, David, Alonso, Covadonga, Campillo, Nuria E., Martinez, Ana   +10 more
openaire   +3 more sources

Drug treatment of COVID-19 infection

Current Opinion in Pulmonary Medicine, 2023
Purpose of review COVID-19 pandemic has caused more than 6.6 million deaths globally. Tremendous efforts have been committed for the development of new and repurposed drugs for the treatment of COVID-19. Although different international and national guidelines share consensus in the management of COVID-19 disease with different
Lui, Grace, Guaraldi, Giovanni
openaire   +2 more sources

Drug repurposing for the treatment of COVID-19

Journal of Pharmacological Sciences, 2022
Coronavirus disease 2019 (COVID-19) remains prevalent worldwide since its onset was confirmed in Wuhan, China in 2019. Vaccines against the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have shown a preventive effect against the onset and severity of COVID-19, and social and economic activities are gradually recovering.
Yuri Kato, Kazuhiro Nishiyama, Akiyuki Nishimura, Takamasa Noda, Kaori Okabe, Takahiro Kusakabe, Yasunari Kanda, Motohiro Nishida   +7 more
openaire   +3 more sources

Drugs for COVID-19 Treatment: A New Challenge

Applied Biochemistry and Biotechnology, 2023
COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficient drugs that can carry out the end of the deadly ...
Pratik Talukder, Arunima Saha, Sohini Roy, Gargi Ghosh, Debshikha Dutta Roy, Snejuti Barua   +5 more
openaire   +2 more sources

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates

Molecules, 2022
In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the province of Wuhan, China.
Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, Miguel Viveiros, Celso Cunha   +4 more
doaj   +1 more source

Drug interactions in COVID-19 treatment. Systematic review [PDF]

Farmacja Polska, 2022
The COVID-19 pandemic has driven the experimental, off-label treatments with co-administration of supportive therapies for many patients with severe infections and coexisting chronic conditions. This situation has inevitably led to polypharmacy, which is
Arkadiusz Adamiszak, Tomasz Torliński, Edmund Grześkowiak, Alicja Bartkowska-Śniatkowska, Agnieszka Bienert   +4 more
doaj   +1 more source

Reuse of drugs in the treatment of COVID-19

Research, Society and Development, 2022
After an outbreak of atypical pneumonia in the city of Wuhan, China, there were epidemiological alerts due to the unknown factor. On January 7, 2020, Chinese scientists isolated a strain of coronavirus, in which the etiologic agent was identified. It quickly spread around the world and, therefore, it was declared a pandemic on March 11, 2020. From then
Alessandra Isabô Neri, Lílian Carla Carneiro, Cristiene Costa Carneiro, Aroldo Vieira de Moraes Filho, Lee Chen-Chen   +4 more
openaire   +2 more sources

CSF3 Is a Potential Drug Target for the Treatment of COVID-19 [PDF]

Frontiers in Physiology, 2021
Coronavirus Disease 2019 (COVID-19) is an acute respiratory infectious disease that appeared at the end of 2019. As of July 2020, the cumulative number of infections and deaths have exceeded 15 million and 630,000, respectively. And new cases are increasing.
Chao Fang, Chao Fang, Jie Mei, Huixiang Tian, Yu-Ligh Liou, Dingchao Rong, Wei Zhang, Qianjin Liao, Nayiyuan Wu, Nayiyuan Wu   +9 more
openaire   +3 more sources

Knowledge-Graph-Based Drug Repositioning against COVID-19 by Graph Convolutional Network with Attention Mechanism

Future Internet, 2021
The current global crisis caused by COVID-19 almost halted normal life in most parts of the world. Due to the long development cycle for new drugs, drug repositioning becomes an effective method of screening drugs for COVID-19. To find suitable drugs for
Mingxuan Che, Kui Yao, Chao Che, Zhangwei Cao, Fanchen Kong   +4 more
doaj   +1 more source